| 04/30/2026 7:34 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/23/2026 6:59 AM | Can-Fite BioPharma (1536196) Issuer Tamir Ilan (2131467) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/06/2026 3:15 PM | Can-Fite BioPharma (1536196) Issuer Regev Guy (1536174) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 04/05/2026 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 04/03/2026 4:07 PM | Can-Fite BioPharma (1536196) Filer | Form 424B3 | |
| 03/31/2026 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 03/31/2026 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 03/30/2026 6:22 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/26/2026 9:05 AM | Can-Fite BioPharma (1536196) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 03/26/2026 8:29 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for CANF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Can-Fite BioPharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/18/2026 7:09 AM | Can-Fite BioPharma (1536196) Issuer Farbstein Motti (2116362) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:10 AM | Can-Fite BioPharma (1536196) Issuer Fishman Pnina (1536172) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:12 AM | Can-Fite BioPharma (1536196) Issuer Fishman Sari (2116402) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:13 AM | Can-Fite BioPharma (1536196) Issuer Sartani Abraham (1331868) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 7:14 AM | Bornstein Yoseph (1690100) Reporting Can-Fite BioPharma (1536196) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/17/2026 6:50 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 3:30 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/05/2026 6:29 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/05/2026 6:31 AM | Can-Fite BioPharma (1536196) Filer | Form 424B3 | |
| 03/04/2026 6:05 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/03/2026 3:39 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 6:01 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/09/2026 6:12 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/05/2026 6:03 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/27/2026 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/20/2026 6:01 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/16/2026 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 5:03 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/23/2025 3:50 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/16/2025 8:21 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/21/2025 3:30 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/21/2025 3:32 PM | Can-Fite BioPharma (1536196) Filer | Form 424B3 | |
| 11/20/2025 6:02 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 6:01 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/10/2025 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/03/2025 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/15/2025 6:10 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/11/2025 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 09/11/2025 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 09/08/2025 4:24 PM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
|
| 09/08/2025 4:27 PM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
| 09/08/2025 9:19 AM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
| 09/08/2025 9:25 AM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
| 08/28/2025 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
| 08/28/2025 3:17 PM | Can-Fite BioPharma (1536196) Filer | Form POS AM | |
| 08/28/2025 7:49 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2025 6:08 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/29/2025 8:57 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/29/2025 9:03 AM | Can-Fite BioPharma (1536196) Filer | Form 424B4 | |
| 07/28/2025 11:15 PM | Can-Fite BioPharma (1536196) Filer | Form EFFECT | |
| 07/28/2025 6:02 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/25/2025 1:34 PM | Can-Fite BioPharma (1536196) Filer | Form F-1/A | |
| 06/23/2025 3:15 PM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/16/2025 8:02 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/05/2025 7:10 AM | Can-Fite BioPharma (1536196) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |